 "Can weight-loss drugs Ozempic and Wegovy cause blindness? – Firstpost")
The world has long been concerned about obesity. It has long been known for its connections to non-communicable diseases like diabetes, cardiovascular disease, and hypertension. Initially presented as a simple fix for this issue, Ozempic and Wegovy quickly gained popularity as weight loss choices, even among Hollywood celebrities. A new study published on Wednesday in the … Read more
 "What ‘unbelievable demand’ for weight-loss drugs adds up to for maker Lilly – Firstpost")
Increased manufacturing capacity for Eli Lilly’s highly sought after weight-loss drug Zepbound drove the company to raise its annual sales forecast by $3 billion on Thursday, and its share jumped as much as 14 per cent. Lilly also raised its 2024 profit forecast and said sales of Zepbound crossed $1 billion for the first time … Read more
About 44% of U.S. employers with 500 or more employees cover drugs for weight loss in 2024, up from 41% in 2023, according to a survey from consulting firm Mercer released on Wednesday. Mercer also said 64% of U.S. employers with over 20,000 employees covered weight-loss drugs in 2024, compared with 56% last year. That … Read more
LONDON: Novo Nordisk signed a research tie-up with US biotech firm Metaphore on Thursday to develop next-generation obesity drugs.Why it’s Important Danish drugmaker Novo is trying to expand beyond its blockbuster obesity drug Wegovy with at least eight other treatments in its R&D pipeline for the condition. The collaboration will use Metaphore’s tech platform to … Read more
